FTC Probe Into Rx Middlemen May Spark Industry Shakeup
Concerns that pharmaceutical middlemen inflate drug prices and harm patients have led the Federal Trade Commission to launch a probe into the largely unregulated industry, and legal experts say the move...To view the full article, register now.
Already a subscriber? Click here to view full article